Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesCannabix Technologies Inc

Cannabix Technologies Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.4 CAD 0.00(0%)
Last update at 2026-11-06T16:54:00Z
VOLUME
18800
Market Cap
88.26M

Momentum Score

…

Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydrocannabinol (THC) detection and quantification; Cannabix breath collection unit and breath cartridge for human breath sample collection, storage, and transportation. The company also provides BreathLogix alcohol breathalyzer, an autonomous alcohol screening system that enables screening of employees, contractors, and visitors in mining, construction, and oil and gas industries; and BreathLogix Connect (BLC), a cloud platform that is designed for streamlining data. It has a strategic partnership and development agreement with Omega Laboratories Inc. for the development and commercialization of the MBT technology. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.40
Low
0.42
High
52 Week Price Range
0.46
Low
0.95
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Cannabix Technologies Inc develops breathalyzer-style screening devices intended to detect recent cannabis use for potential law enforcement and workplace testing. Long-term growth drivers include expanding cannabis legalization, greater regulatory focus on impaired driving, and demand for portable, objective roadside screening. Investors may find the company attractive because it appears positioned to benefit from regulatory adoption of standardized testing if its technology proves reliable and achieves commercialization.
Principal risks are early-stage execution and regulatory approval challenges, limited commercialization and revenue to date, competitive alternatives, and financing uncertainty.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.40
Dividend Yield
-
Revenue TTM
0.16M
Revenue Per Share
0.00
Gross Profit TTM
0.03M
Debt / Equity
-
ROE
-271.42%
Net Debt
-
ROCE
-185.45%
Diluted EPS TTM
-0.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Type yearly yearly yearly yearly yearly
Date 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Income before tax -4.69M -3.13M -2.14M -3.37M -9.24M
Net income -4.69M -3.13M -2.14M -3.37M -9.24M
Selling general administrative 1.74M 1.91M 0.87M 2.11M 8.18M
Reconciled depreciation 0.17M 0.15M 0.13M 0.03M 0.03M
Ebit - - -2.14M -3.14M -9.13M
Ebitda - - -1.98M -3.37M -9.28M
Operating income -4.76M -3.30M -2.28M -3.40M -9.31M
Interest expense 0.01M 0.02M 0.04M 0.00M 0.00M
Interest income 0.10M 0.17M 0.14M 0.03M 0.07M
Net interest income 0.09M 0.17M 0.14M 0.03M 0.07M
Total revenue 0.00M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 4.76M 3.30M 2.28M 3.40M 9.31M
Total other income expense net -0.02M - - - -
Net income from continuing ops -4.69M -3.13M -2.14M -3.37M -9.24M
Net income applicable to common shares - -3.13M -2.14M -3.37M -9.24M
Breakdown 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Type yearly yearly yearly yearly yearly
Date 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Total assets 3.00M 4.70M 6.95M 8.76M 10.38M
Total liab 0.45M 0.25M 0.24M 0.12M 0.08M
Total stockholder equity 2.55M 4.45M 6.71M 8.64M 10.30M
Common stock - - 33.27M 33.27M 32.14M
Capital stock 34.16M 33.27M 33.27M 33.27M 32.14M
Retained earnings -42.13M -37.45M -34.32M -32.18M -28.82M
Other assets - - 0.05M 0.05M 0.05M
Cash 2.30M 4.21M 5.97M 8.45M 10.10M
Total current liabilities 0.43M 0.24M 0.23M 0.12M 0.08M
Short term debt - - 0.00M 0.00M 0.00M
Other stockholder equity - - 7.76M 7.56M 6.98M
Property plant equipment - - 0.31M 0.19M 0.22M
Total current assets 2.69M 4.37M 6.59M 8.52M 10.12M
Net tangible assets - - 6.71M 8.64M 10.30M
Short term investments 0.05M 0.05M 0.50M 0.50M 0.50M
Net receivables 0.07M 0.05M 0.05M 0.05M 0.01M
Accounts payable 0.29M 0.09M 0.10M 0.12M 0.08M
Non currrent assets other - - 0.05M 0.05M 0.05M
Non current assets total 0.30M 0.33M 0.36M 0.24M 0.26M
Capital lease obligations 0.16M 0.15M 0.13M 0.00M -
Long term debt total - - 0.01M 0.00M 0.00M
Breakdown 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Type yearly yearly yearly yearly yearly
Date 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Investments 0.00M -0.03M -0.03M -0.00M -0.12M
Change to liabilities - - -0.02M 0.04M -0.01M
Total cashflows from investing activities - -0.03M -0.03M -0.00M -0.12M
Net borrowings -0.15M -0.14M -0.12M -0.12M -0.12M
Total cash from financing activities -0.06M -0.14M 0.01M 0.49M 3.49M
Change to operating activities - - -0.05M -0.01M 0.03M
Net income -4.69M -3.13M -2.14M -3.37M -9.24M
Change in cash -1.91M -2.26M -1.98M -1.64M 1.66M
Begin period cash flow 4.21M 6.47M 8.45M 10.10M 8.44M
End period cash flow 2.30M 4.21M 6.47M 8.45M 10.10M
Total cash from operating activities -1.84M -2.08M -1.97M -2.13M -1.71M
Issuance of capital stock - 0.00M 0.14M 0.49M 3.49M
Depreciation 0.17M 0.15M 0.13M 0.03M 0.03M
Other cashflows from investing activities - -0.00M - 0.00M -0.05M
Change to account receivables - - -0.00M -0.03M 0.08M
Sale purchase of stock - - 0.00M 0.49M 3.49M
Other cashflows from financing activities - - 0.14M - -
Change to netincome - - 0.11M 1.21M 7.41M
Capital expenditures 0.02M 0.03M 0.03M 0.00M 0.08M
Change in working capital -0.04M 0.00M -0.06M -0.00M 0.10M
Stock based compensation 1.26M 0.87M 0.07M 1.21M 0.81M
Other non cash items 1.44M 0.02M 0.04M - 6.60M
Free cash flow -1.86M -2.11M -2.00M -2.13M -1.79M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BLO
Cannabix Technologies Inc		 -
-%		 0.40 - - 556.83 57.80 564.68 -11.28
ASTI
Aquarius Surgical Technologies Inc		 -
-%		 0.01 - - 5.52 31.44 96.08 56.94

Profile*

Cannabix Technologies Inc

Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydrocannabinol (THC) detection and quantification; Cannabix breath collection unit and breath cartridge for human breath sample collection, storage, and transportation. The company also provides BreathLogix alcohol breathalyzer, an autonomous alcohol screening system that enables screening of employees, contractors, and visitors in mining, construction, and oil and gas industries; and BreathLogix Connect (BLC), a cloud platform that is designed for streamlining data. It has a strategic partnership and development agreement with Omega Laboratories Inc. for the development and commercialization of the MBT technology. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.

501 - 3292 Production Way, Burnaby, BC, Canada, V5A 4R4

604 551 7831

https://cannabixtechnologies.com

Name Title Year Born
Mr. Ravinder S. Mlait B.A., M.B.A. CEO & Director 1976
Mr. Bryan E. Loree B.A., C.M.A., CPA CFO, Corporate Secretary & Director 1976
Dr. Moe Paknahad Ph.D. Vice President of Technology Development NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…